학술논문

Presence of Prior-to-Treatment BCR-ABL Mutations In CD34+CD38-Stem Cells of Newly Diagnosed Chronic Phase CML Patients and Their Correlation with Imatinib Resistance: Implications of Cancer Pharmacogenomics and Pre-Therapeutic Genetic Testing In Personalized Treatment of BCR-ABL plus Leukemia.